Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fphar.2026.1883092.s002BackgroundBrain metastasis remains a major cause of mortality in patients with advanced non-small cell lung cancer, whereas effective radiosensitization strategies are constrained by heterogeneous tumor responses and the tolerance of normal brain tissue. Ferumoxytol, a clinically used iron oxide nanoparticle formulation, has emerging translational potential as an iron-modulating agent. However, whether Ferumoxytol enhances radiosensitivity in brain-metastatic lung cancer cells and the mechanisms underlying this effect remain unclear.MethodsPC-9 lung adenocarcinoma cells and NCI-H1915 brain-metastatic lung adenocarcinoma cells were used to evaluate ferumoxytol under basal and irradiated conditions. Ferroptosis-associated phenotypes, oxidative stress, clonogenic survival, and cell-cycle distribution were assessed. TMT-based proteomics and public single-cell and spatial transcriptomic analyses were used for candidate prioritization and disease-context support. NCOA4 was evaluated by siRNA-mediated loss of function, single-dose clonogenic assays, time-resolved NCOA4/FTH1 immunoblotting, bafilomycin A1-based autophagic-flux analysis, and endogenous NCOA4-FTH1 co-immunoprecipitation.ResultsFerumoxytol induced mitochondrial, biochemical, and molecular changes consistent with ferroptosis and enhanced irradiation-associated ROS accumulation, lipid peroxidation, and loss of clonogenic survival. Proteomic analysis prioritized NCOA4, while public transcriptomic analyses provided associative disease-context support. In H1915 cells, NCOA4 silencing attenuated combined-treatment Fe2+ accumulation, oxidative stress, and γ-H2AX induction. The incremental reduction in colony formation produced by adding ferumoxytol to irradiation was also reduced after NCOA4 knockdown in H1915 cells and was no longer significant in PC-9 cells. Time-resolved immunoblotting showed marked FTH1 accumulation rather than net FTH1 depletion, with a late reduction in NCOA4. Bafilomycin A1 caused further LC3B-II and SQSTM1/p62 accumulation under IR + F, consistent with ongoing autophagic turnover, whereas co-immunoprecipitation showed greater normalized recovery of FTH1 in NCOA4 immunoprecipitates after IR + F.ConclusionFerumoxytol enhances ferroptosis-associated oxidative injury and radiosensitivity in the tested lung cancer cell models. The combined loss-of-function, autophagic-flux, and protein-interaction data support the involvement of NCOA4-associated ferritin handling and iron mobilization. However, the observed FTH1 accumulation and the absence of iron-chelator rescue, cargo-specific lysosomal tracking, and in vivo validation preclude a definitive claim of canonical ferritinophagy or clinical efficacy.
Keyword(s):
brain metastasis; ferroptosis; ferumoxytol; iron metabolism; lung cancer.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)